Abound Wealth Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.47K Buy
25
+2
+9% +$465 ﹤0.01% 676
2026
Q2
$5.36K Sell
23
-25
-52% -$5.2K ﹤0.01% 591
2026
Q1
$10.2K Hold
48
– – ﹤0.01% 545
2025
Q4
$9.9K Buy
48
+1
+2% +$188 ﹤0.01% 508
2025
Q3
$7.32K Buy
47
+1
+2% +$154 ﹤0.01% 559
2025
Q2
$7.74K Hold
46
– – ﹤0.01% 490
2025
Q1
$6.35K Sell
46
-14
-23% -$1.78K ﹤0.01% 486
2024
Q4
$7.1K Buy
60
+4
+7% +$467 ﹤0.01% 459
2024
Q3
$6.2K Buy
56
+16
+40% +$1.67K ﹤0.01% 506
2024
Q2
$3.94K Sell
40
-4
-9% -$408 ﹤0.01% 543
2024
Q1
$4.94K Sell
44
-5
-10% -$539 ﹤0.01% 526
2023
Q4
$4.96K Sell
49
-9
-16% -$893 ﹤0.01% 505
2023
Q3
$5.04K Buy
58
+9
+18% +$814 ﹤0.01% 459
2023
Q2
$4.64K Buy
49
+4
+9% +$338 ﹤0.01% 500
2023
Q1
$3.4K Buy
45
+12
+36% +$905 ﹤0.01% 496
2022
Q4
$2.54K Buy
33
+13
+65% +$988 ﹤0.01% 500
2022
Q3
$1.34K Buy
+20
New +$1.27K ﹤0.01% 559

Other funds holding CAH

Abound Wealth Management's CAH Position: Q3 2026 in Review

Abound Wealth Management increased its Cardinal Health (CAH) stake by 8.7% in Q3 2026, buying an estimated $465 and bringing the position to 25 shares worth $5.47K. The position accounts for ﹤0.01% of the portfolio, ranked #676.

Abound Wealth Management first reported a position in CAH in Q3 2022 and has held it in 17 quarters since. The position peaked at $10.2K in Q1 2026. 1,061 funds tracked by Wall St. Rank hold CAH as of Q3 2026.

  • Abound Wealth Management held 25 shares of Cardinal Health worth $5.47K as of Q3 2026.
  • Abound Wealth Management bought 2 Cardinal Health shares in Q3 2026, an estimated $465.
  • Cardinal Health made up ﹤0.01% of Abound Wealth Management's portfolio in Q3 2026, its #676 holding.
  • Abound Wealth Management first reported a position in Cardinal Health in Q3 2022 and has held it in 17 quarters since.
  • Abound Wealth Management's Cardinal Health position peaked at $10.2K in Q1 2026.
  • 1,061 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2026.

Based on Abound Wealth Management's 13F filing for Q3 2026, filed 26 Oct 2026.